185 related articles for article (PubMed ID: 2790000)
1. Phosphonate analogues of carboxypeptidase A substrates are potent transition-state analogue inhibitors.
Hanson JE; Kaplan AP; Bartlett PA
Biochemistry; 1989 Jul; 28(15):6294-305. PubMed ID: 2790000
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of an inhibitor of carboxypeptidase A with a Ki value in the femtomolar range.
Kaplan AP; Bartlett PA
Biochemistry; 1991 Aug; 30(33):8165-70. PubMed ID: 1868091
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the complex of carboxypeptidase A with a strongly bound phosphonate in a new crystalline form: comparison with structures of other complexes.
Kim H; Lipscomb WN
Biochemistry; 1990 Jun; 29(23):5546-55. PubMed ID: 2386784
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the structures of three carboxypeptidase A-phosphonate complexes determined by X-ray crystallography.
Kim H; Lipscomb WN
Biochemistry; 1991 Aug; 30(33):8171-80. PubMed ID: 1868092
[TBL] [Abstract][Full Text] [Related]
5. Slow- and fast-binding inhibitors of thermolysin display different modes of binding: crystallographic analysis of extended phosphonamidate transition-state analogues.
Holden HM; Tronrud DE; Monzingo AF; Weaver LH; Matthews BW
Biochemistry; 1987 Dec; 26(26):8542-53. PubMed ID: 3442675
[TBL] [Abstract][Full Text] [Related]
6. Crystallographic analysis of transition-state mimics bound to penicillopepsin: phosphorus-containing peptide analogues.
Fraser ME; Strynadka NC; Bartlett PA; Hanson JE; James MN
Biochemistry; 1992 Jun; 31(22):5201-14. PubMed ID: 1606144
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of alpha-lytic protease complexes with irreversibly bound phosphonate esters.
Bone R; Sampson NS; Bartlett PA; Agard DA
Biochemistry; 1991 Feb; 30(8):2263-72. PubMed ID: 1998685
[TBL] [Abstract][Full Text] [Related]
8. Possible role for water dissociation in the slow binding of phosphorus-containing transition-state-analogue inhibitors of thermolysin.
Bartlett PA; Marlowe CK
Biochemistry; 1987 Dec; 26(26):8553-61. PubMed ID: 3442676
[TBL] [Abstract][Full Text] [Related]
9. Effect of polar head groups on the interactions of phospholipase A2 with phosphonate transition-state analogues.
Yu L; Dennis EA
Biochemistry; 1993 Sep; 32(38):10185-92. PubMed ID: 8399145
[TBL] [Abstract][Full Text] [Related]
10. Transition-state characterization: a new approach combining inhibitor analogues and variation in enzyme structure.
Phillips MA; Kaplan AP; Rutter WJ; Bartlett PA
Biochemistry; 1992 Feb; 31(4):959-63. PubMed ID: 1734971
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective inhibition of glutamate carboxypeptidase by chiral phosphonothioic acids.
Lu H; Berkman CE
Bioorg Med Chem; 2001 Feb; 9(2):395-402. PubMed ID: 11249132
[TBL] [Abstract][Full Text] [Related]
12. Phosphonamidates as transition-state analogue inhibitors of thermolysin.
Bartlett PA; Marlowe CK
Biochemistry; 1983 Sep; 22(20):4618-24. PubMed ID: 6626519
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of intrinsic binding energy from a hydrogen bonding group in an enzyme inhibitor.
Bartlett PA; Marlowe CK
Science; 1987 Jan; 235(4788):569-71. PubMed ID: 3810155
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of serine proteases by peptidyl fluoromethyl ketones.
Imperiali B; Abeles RH
Biochemistry; 1986 Jul; 25(13):3760-7. PubMed ID: 3527255
[TBL] [Abstract][Full Text] [Related]
15. 3-Phosphonopropionic acids inhibit carboxypeptidase A as multisubstrate analogues or transition-state analogues.
Grobelny D; Goli UB; Galardy RE
Biochem J; 1985 Nov; 232(1):15-9. PubMed ID: 4084224
[TBL] [Abstract][Full Text] [Related]
16. Excess zinc ions are a competitive inhibitor for carboxypeptidase A.
Hirose J; Ando S; Kidani Y
Biochemistry; 1987 Oct; 26(20):6561-5. PubMed ID: 3427026
[TBL] [Abstract][Full Text] [Related]
17. Phosphinic peptide analogues as potent inhibitors of Corynebacterium rathayii bacterial collagenase.
Yiotakis A; Lecoq A; Nicolaou A; Labadie J; Dive V
Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):323-7. PubMed ID: 7945258
[TBL] [Abstract][Full Text] [Related]
18. Design of mechanism-based carboxypeptidase A inactivators on the basis of the X-ray crystal structure and catalytic reaction pathway.
Lee KJ; Kim DH
Bioorg Med Chem; 1998 Sep; 6(9):1613-22. PubMed ID: 9801832
[TBL] [Abstract][Full Text] [Related]
19. Kinetics and mechanism of beta-lactamase inhibition by phosphonamidates: the quest for a proton.
Rahil J; Pratt RF
Biochemistry; 1993 Oct; 32(40):10763-72. PubMed ID: 8399224
[TBL] [Abstract][Full Text] [Related]
20. Peptidic phosphonylating agents as irreversible inhibitors of serine proteases and models of the tetrahedral intermediates.
Sampson NS; Bartlett PA
Biochemistry; 1991 Feb; 30(8):2255-63. PubMed ID: 1998684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
